How will Alcor sustain itself for the duration of my cryopreservation?
In 1997, Alcor created an irrevocable Patient Care Trust. This trust was established to ensure the security of the funds allotted to the long-term care of Alcor’s cryopatients. Using a conservative estimate, the funds should generate more than enough money to cover patient maintenance indefinitely. Alcor places $25,000 into the Trust for each neuropatient and $65,000 for each whole body patient. The Trust holds the mortgage of the building housing Alcor patients. All patient care expenses have been more than adequately covered by the mortgage payments alone, allowing the rest of the Trust investments (primarily stock and bond investments managed by Morgan Stanley) to grow untouched. Alcor anticipates future growth of the Trust to fund research into the technology of patient repair and resuscitation. The more optimistic among us predict the growth in these investment funds during the next few decades will be enough to pay for the entire patient resuscitation procedure. The full text of
